SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IPCA Laboratories informs about postal ballot notice

27 Feb 2024 Evaluate
IPCA Laboratories has informed that the Company has on 26ht February, 2024 completed the electronic dispatch of the Postal Ballot Notice under the provisions of Section 110 of the Companies Act, 2013, to the Members whose names appear in the Register of Members/Beneficial owners as on the cut-off date i.e. 23rd February, 2024 seeking assent / dissent of the Members through Postal Ballot only through e-voting for the following special resolutions to be passed as per the postal ballot notice dated 14lh February, 2024: To consider re-appointment of Kamal Kishore Seth (DIN 00194986) as an Independent Director for 2nd term of five consecutive years with effect from 29th March, 2024 till 28th March, 2029 and continuation in his appointment even though he has already attained the age of 75 years on 12th May, 2020; To consider appointment of Dr. (Ms.) Swati Arvind Patankar (DIN 06594600) as an Independent Director of the Company for a period of five consecutive years from 14th February, 2024 to 13th February, 2029; To consider and approve Ipca Laboratories Ltd - Employees Stock Option Scheme 2024 (Ipca ESOS 2024) - grant of stock options to eligible employees of the Company. The Postal Ballot Notice is also available on the Company's website www.ipca.com and website of National Securities Depository Limited (NSDL), www.evotinq.nsdl.com. These details are also available on the website of the Stock Exchanges where the shares of the Company are listed: BSE (www.bseindia.com) and The National Stock Exchange of India (www.nseindia.com).

The above information is a part of company’s filings submitted to BSE.

Ipca Laboratories Share Price

1468.00 6.75 (0.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×